Ocasa
Freight & Logistics Services · Argentina · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Avenida Vélez Sársfield, Buenos Aires, B...Phone Number
+54 8108886227Website
www.ocasa.comRevenue
$653.2 MillionIndustry
About Ocasa
Ocasa is a logistics company specializing in life sciences solutions, headquartered in Buenos Aires, Argentina. The company provides specialized supply chain and distribution services tailored to the unique requirements of the life sciences industry. Ocasa focuses on handling temperature-sensitive pharmaceuticals, medical devices, biotechnology products, and other healthcare-related materials that require strict regulatory compliance and controlled handling throughout the logistics process. With expertise in cold chain management and pharmaceutical distribution, Ocasa serves clients across the healthcare and life sciences sectors, ensuring products maintain their integrity from origin to destination. The company's operations are designed to meet the stringent quality standards and regulatory requirements essential to the pharmaceutical and biotechnology industries in Latin America.Explore more
SIC Code 47,473NAICS Code 48,488Show moreOcasa Org Chart
Compare Similar Companies to Ocasa
Compare insights from companies similar to Ocasa, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ocasa Tech Stack
A closer look at the technologies used by Ocasa
Top Freight & Logistics Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ocasa
Sign Up For FreeTo access detailed company insights
Ocasa is a logistics company specializing in life sciences solutions, headquartered in Buenos Aires, Argentina. The company provides specialized supply chain and distribution services tailored to the unique requirements of the life sciences industry. Ocasa focuses on handling temperature-sensitive pharmaceuticals, medical devices, biotechnology pro... Read More
